Stokes Capital Advisors LLC Invests $6.37 Million in Marsh & McLennan Companies, Inc. $MRSH

Stokes Capital Advisors LLC bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 36,750 shares of the financial services provider’s stock, valued at approximately $6,374,000.

Several other institutional investors have also recently made changes to their positions in MRSH. Procyon Advisors LLC grew its holdings in Marsh & McLennan Companies by 2.5% during the 4th quarter. Procyon Advisors LLC now owns 2,279 shares of the financial services provider’s stock valued at $423,000 after buying an additional 56 shares in the last quarter. PFG Investments LLC grew its stake in Marsh & McLennan Companies by 3.3% during the fourth quarter. PFG Investments LLC now owns 1,758 shares of the financial services provider’s stock valued at $326,000 after acquiring an additional 56 shares in the last quarter. Lindenwold Advisors INC lifted its stake in Marsh & McLennan Companies by 0.4% in the 3rd quarter. Lindenwold Advisors INC now owns 14,994 shares of the financial services provider’s stock worth $3,022,000 after purchasing an additional 62 shares in the last quarter. SeaCrest Wealth Management LLC boosted its holdings in Marsh & McLennan Companies by 3.9% in the 4th quarter. SeaCrest Wealth Management LLC now owns 1,673 shares of the financial services provider’s stock valued at $306,000 after purchasing an additional 63 shares during the period. Finally, First Heartland Consultants Inc. grew its position in shares of Marsh & McLennan Companies by 7.1% during the 3rd quarter. First Heartland Consultants Inc. now owns 1,000 shares of the financial services provider’s stock valued at $202,000 after purchasing an additional 66 shares in the last quarter. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies Price Performance

Shares of NYSE MRSH opened at $162.22 on Friday. The stock has a market cap of $78.37 billion, a P/E ratio of 20.28, a PEG ratio of 2.42 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 1-year low of $156.60 and a 1-year high of $219.71. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSH) last issued its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. The business had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. Equities research analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current year.

Insiders Place Their Bets

In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. This represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Bank of America lowered their price objective on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a research report on Tuesday, April 14th. UBS Group decreased their target price on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating on the stock in a research note on Tuesday, June 9th. Citigroup upgraded Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target for the company in a research report on Wednesday, May 6th. Barclays decreased their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 8th. Finally, Weiss Ratings lowered shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $200.19.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.